The University of Alabama at Birmingham Research Foundation

Patent Applications and Registrations

Patent applications and USPTO patent grants for The University of Alabama at Birmingham Research Foundation.The latest application filed is for "consensus/ancestral immunogens".

Company Profile

1.17.3

The University of Alabama at Birmingham Research Foundation - Birmingham AL US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Consensus/ancestral immunogens Grant 10,946,090 - Haynes , et al. March 16, 2	2021-03-16
Consensus/ancestral Immunogens App 20180296665 - Haynes; Barton F. ; et al.	2018-10-18
Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins Grant 9,821,053 - Korber , et al. November 21, 2	2017-11-21
Nucleic acids encoding mosaic HIV-1 gag proteins Grant 9,492,532 - Korber , et al. November 15, 2	2016-11-15
Polyvalent Vaccine App 20160067329 - KORBER; Bette T. ; et al.	2016-03-10
Polyvalent Vaccine App 20150359875 - KORBER; Bette T. ; et al.	2015-12-17
Nucleic acids encoding mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens Grant 9,011,873 - Korber , et al. April 21, 2	2015-04-21
Human immunodeficiency virus type 1 clade M mosaic gag polypeptides Grant 9,011,875 - Korber , et al. April 21, 2	2015-04-21
Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins Grant 8,119,140 - Korber , et al. February 21, 2	2012-02-21
Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins Grant 8,071,107 - Haynes , et al. December 6, 2	2011-12-06
Oxidant scavengers Grant 6,583,132 - Crapo , et al. June 24, 2	2003-06-24
Oxidant scavengers Grant 5,994,339 - Crapo , et al. November 30, 1	1999-11-30
Purified retroviral constitutive transport enhancer elements that enhance nucleocytoplasmic transport of mRNA, and methods of making and using the elements Grant 5,880,276 - Hammarskjold , et al. March 9, 1	1999-03-09
Antioxidants Grant 5,747,026 - Crapo , et al. May 5, 1	1998-05-05
Purine nucleoside phosphorylase gene therapy for human malignancy Grant 5,552,311 - Sorscher , et al. September 3, 1	1996-09-03
Infant positioning device Grant 5,524,640 - Lisak , et al. June 11, 1	1996-06-11
Calixarene chloride-channel blockers Grant 5,489,612 - Atwood , et al. February 6, 1	1996-02-06
Reversible mechanochemical engines comprised of bioelastomers capable of modulable inverse temperature transitions for the interconversion of chemical and mechanical work Grant 5,032,271 - Urry July 16, 1	1991-07-16
Bioelastomer containing tetra/penta-peptide units Grant 4,898,926 - Urry February 6, 1	1990-02-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.